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Abstract
Background: Antibodies that protect against Plasmodium falciparum (Pf) malaria are only acquired after years of repeated
infections. The B cell biology that underlies this observation is poorly understood. We previously reported that ‘‘atypical’’
memory B cells are increased in children and adults exposed to intense Pf transmission in Mali, similar to what has been
observed in individuals infected with HIV. In this study we examined B cell subsets of Pf -infected adults in Peru and Mali to
determine if Pf transmission intensity correlates with atypical memory B cell expansion.
Methodology/Principal Findings: In this cross-sectional study venous blood was collected from adults in areas of zero (U.S.,
n=10), low (Peru, n=18) and high (Mali, n=12) Pf transmission. Adults in Peru and Mali were infected with Pf at the time of
blood collection. Thawed lymphocytes were analyzed by flow cytometry to quantify B cell subsets, including atypical
memory B cells, defined by the cell surface markers CD19
+ CD20
+ CD21
2 CD27
2 CD10
2. In Peru, the mean level of atypical
memory B cells, as a percent of total B cells, was higher than U.S. adults (Peru mean: 5.4% [95% CI: 3.61–7.28]; U.S. mean:
1.4% [95% CI: 0.92–1.81]; p,0.0001) but lower than Malian adults (Mali mean 13.1% [95% CI: 10.68–15.57]; p=0.0001). In
Peru, individuals self-reporting >1 prior malaria episodes had a higher percentage of atypical memory B cells compared to
those reporting no prior episodes (>1 prior episodes mean: 6.6% [95% CI: 4.09–9.11]; no prior episodes mean: 3.1% [95% CI:
1.52–4.73]; p=0.028).
Conclusions/Significance: Compared to Pf-naive controls, atypical memory B cells were increased in Peruvian adults
exposed to low Pf transmission, and further increased in Malian adults exposed to intense Pf transmission. Understanding
the origin, function and antigen specificity of atypical memory B cells in the context of Pf infection could contribute to our
understanding of naturally-acquired malaria immunity.
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Introduction
Passive transfer studies in humans indicate that antibodies (Abs)
play a critical role in controlling the disease associated with the
asexual blood stages of Plasmodium falciparum (Pf) malaria [1,2].
However, Abs that protect against clinical malaria are only
acquired after repeated infections and may be relatively short-lived
[3,4]. This stands in contrast to the long-term or even lifelong Ab-
mediated immunity that follows one or a few exposures to many
viral and bacterial antigens, either through natural exposure or
vaccination [5].
Recent advances in B cell biology have now established that
long-term protective humoral immunity requires the generation
and maintenance of memory B cells (MBCs) and long-lived
plasma cells (LLPCs), defined by the cell surface markers
CD19+CD27+CD382 and CD19+CD27++CD38+++, respec-
tively (reviewed in [6,7,8]). The process of generating MBCs and
LLPCs begins when naı ¨ve B cells encounter their cognate antigen
near the interface of B and T cell areas of secondary lymphoid
tissue. Several studies suggest that high-affinity antigen binding
drives naı ¨ve B cells to differentiate into short-lived, isotype-
switched plasma cells (PCs) within the extra-follicular region which
contributes to the initial control of infections. In contrast, lower
affinity binding selects for entry of naı ¨ve B cells into follicles where
germinal centers are formed. After a period of 7–10 days, during
which the CD4
+ T-cell-dependent process of affinity maturation
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reaction yields LLPCs and MBCs of higher affinity than the initial
wave of short-lived plasma cells (SLPCs). LLPCs migrate to the
bone marrow where they constitutively secrete antibody and
provide a critical first line of defense against re-infection, whereas
MBCs recirculate and mediate recall antibody responses after re-
exposure to their cognate antigen by rapidly proliferating and
differentiating into PCs.
The MBC and LLPC response following exposure to many
pathogens and vaccines is remarkably efficient and durable [5,9].
For example, the smallpox vaccine reliably induces vaccine-
specific MBCs and long-lived Abs that persist for >50 years in the
absence of antigen re-exposure [9]. By comparison, the MBC and
LLPC response to Pf infection appears to be less efficient. Recent
studies in areas of high and low Pf transmission have shown that
MBCs specific for certain Pf blood stage antigens are detectable in
only 30–50% of adults [10,11,12]. Furthermore, the Ab response
to many Pf antigens following natural infection appears to be
dominated by SLPCs rather than LLPCs [4,13]. Although
antigenic variation likely contributes to the delayed acquisition
of antibodies that protect against clinical malaria [14], the
mechanisms underlying what appears to be a relatively inefficient
B cell response to Pf infection remain poorly defined.
We recently reported that Pf exposure in Malian children and
adults is associated with the expansion of a phenotypically distinct
population of MBCs identified by the cell surface markers CD19
+
CD20
+ CD21
2 CD27
2 CD10
2 [15], a B cell subpopulation that
was initially defined by expression of the inhibitory receptor Fc-
receptor-like-4 (FCRL4) [16]. This observation provided a clue
that Pf may modulate the humoral immune response at the level of
MBCs. B cells with a similar phenotype have also been identified
in individuals infected with HIV [17] and HCV [18]. Moir et al.
showed that this subset of B cells in HIV-infected individuals had
undergone isotype class switching and somatic hypermutation, but
compared to naive B cells and classical MBCs, FCRL4
+ MBCs
proliferated less well to BCR-crosslinking and/or the CD40L and
Toll-like receptor 9 (TLR9) agonist CpG, and showed a decreased
ability to differentiate into antibody secreting cells in response to
CpG and the polyclonal activator Staphylococcus aureus Cowan
(SAC) [17]. FCRL4
+ MBCs in HIV-viremic [17] and Pf-exposed
individuals [15] also express high levels of inhibitory receptors and
a profile of lymphoid-homing receptors similar to what is
expressed on exhausted CD8
+ T cells during chronic viral
infections (12). Although the function of FCRL4
+ MBCs remains
unknown in the context of HIV and malaria, Moir et al. suggested
that this subset of hyporesponsive, or ‘exhausted’, FCRL4
+ MBCs
contribute to the B cell deficiencies observed in HIV-infected
individuals [17]. In contrast, Ehrhardt et al. [16], who first
described FCRL4
+ ‘tissue-like’ MBCs in lymphoid tissues of
healthy individuals, suggested that these cells may play a protective
role during infection. Given that the function of FCRL4
+ MBCs in
Pf-exposed individuals is unknown, we refer to this B cell subset in
the context of malaria as ‘atypical’ rather than ‘exhausted’.
To gain further insight into the relationship between atypical
MBCs and Pf infection we examined by flow cytometry the B cell
subsets of Pf -infected adults in Peru and Mali, and Pf-naive adults
in the U.S. The specific objectives of this study were to determine
if atypical MBC expansion is an observation that can be
generalized to Pf-exposed individuals in Peru, and if there is a
correlation between the degree of atypical MBC expansion and Pf
transmission intensity. We observed that atypical MBCs were
expanded in Pf-infected individuals in Peru relative to Pf-naive
individuals, and that the degree of atypical MBC expansion
increased with increasing Pf transmission intensity.
Results
Study subject characteristics
In Peru, PBMCs from 18 adults with symptomatic Pf infection
were analyzed. The mean parasite density was 10,226 asexual
parasites/ml of blood [95% CI: 2,618–17,833]). The average age
of study participants was 40.4 years (range: 20–75 years) and 50%
were female. All 18 adults reported subjective fever, chills and
other symptoms consistent with malaria in the two days prior to
enrolment. At the time of presentation to the study clinic, 6 of 18
participants had a temperature >37.5uC, and 12 self-reported at
least one prior episode of symptomatic malaria diagnosed by blood
smear. Of note, community-wide active surveillance surveys at
this site indicate that up to 40% of Pf infections in adults are
asymptomatic [19], despite the low intensity of Pf transmission. A
detailed description of the study site and design in Peru has been
reported elsewhere [19].
In Mali, PBMCs from 12 adults with asymptomatic Pf infection
were analyzed. The mean parasite density was 410 asexual
parasites/ml of blood [95% CI: -187-1008]). The average age of
study participants was 21.1 years (range: 19–25 years) and 50%
were female. At the time of presentation to the study clinic, all
subjects were afebrile. A detailed description of the study site and
design in Mali has been reported elsewhere [20].
Atypical MBC analysis
We determined if atypical MBCs were detectable in the
peripheral blood of Peruvian adults (n=18) living in an area of
low level Pf transmission by performing FACS analysis on thawed
PBMCs which had been collected during symptomatic Pf
infection. These data were compared to B cell profiles of Pf-naive
U.S. adults (n=10) and Pf-infected asymptomatic Malian adults
(n=12). As a percentage of total B cells, the mean percentage of
atypical MBCs in Peruvian adults was higher than the mean
percentage in U.S. adults (Fig. 1; Peru: 5.4% [95% CI: 3.6–7.3];
U.S.: 1.4% [95% CI: 0.9–1.8; P,0.0001], but lower than the
percentage in Malian adults (Fig. 1; Mali: 13.1% [95% CI: 10.7–
15.6]; P=0.0001 versus Peru]. The low percentage of atypical
MBCs in the peripheral blood of healthy U.S. adults is consistent
with other reports [17]. Stratifying Peruvian adults by a self-
reported history of prior malaria episodes revealed that the mean
percentage of atypical MBCs was higher in those reporting at least
one prior malaria episode (n=12), versus those who reported no
prior malaria episodes (n=6) (Fig. 2; no prior malaria reported:
3.1% [95% CI: 1.5–4.7]; prior malaria reported: 6.6% [95% CI:
4.1–9.1; P=0.028]. Together these data suggest that atypical
MBCs increase as a percentage of total B cells with increasing Pf
exposure.
Phenotypic analysis of other B cell subsets
In addition to the variation we observed in the proportion of
atypical MBCs between study populations in the U.S., Peru, and
Mali, we found significant differences in the proportions of other B
cell subsets (Fig. 3). The proportion of activated MBCs was higher
in Peru (n=12) and Mali (n=13) compared to the U.S. (n=10)
(Peru: 2.5% [95% CI: 1.4–3.6], Mali: 4.0% [95% CI: 3.2–4.8],
U.S.: 0.9% [95% CI: 0.3–1.6]; Peru vs. U.S. p=0.003; Mali vs.
U.S. p=0.0003), consistent with concurrent Pf infection in donors
from Peru and Mali. In addition, the proportion of naı ¨ve B cells
was lower in Peru and Mali compared to the U.S. (Peru: 47.6%
[95% CI: 41.2–54.1], Mali: 54.3% [95% CI: 48.6–59.9], U.S.:
64.2% [95% CI: 56.3–72.0]; Peru vs. U.S. p=0.003; Mali vs. U.S.
p=0.013); and the proportion of classical MBCs was higher in
Peru and Mali compared to the U.S. (Peru: 31.6% [95% CI: 26.5–
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16.6–28.2]; Peru vs. U.S. p=0.04; Mali vs. U.S. p=0.82),
although the difference between the U.S. in Mali did not reach
statistical significance. The decrease in naı ¨ve B cells and increase
in classical MBCs in Peruvians and Malians relative to the U.S.
donors may reflect greater cumulative immunological experience
of study participants in Peru and Mali.
Atypical MBCs and immunoglobulin class switching
Immunoglobulin class switching occurs in germinal center
reactions during the differentiation of naı ¨ve B cells into MBCs. We
assessed class-switching of atypical MBCs by measuring cell
surface expression of IgG by flow cytometry (Fig. 4). The mean
percentage of class-switched atypical MBCs was significantly
higher among individuals in Peru and Mali compared to the U.S.
(Peru: 48.0% [95%CI: 41.1–54.9], Mali: 55.1% [95%CI: 43.3–
66.8], U.S.: 8.1% [95% CI: 5.9–10.3]; Peru vs. U.S., p=0.0001;
Mali vs. U.S., p,0.0001). The higher percentage of class switched
atypical MBCs in individuals from Mali versus individuals from
Peru was not statistically significant (p=0.054). The percentage
difference in class switched atypical MBCs between individuals in
Peru who did, and did not self-report prior malaria was not
statistically significant (Peru, no prior malaria: 44.8% [95% CI:
28.58–60.98], Peru, prior malaria: 49.6% [95% CI: 41.12–58.10];
p=0.64).
Discussion
We reported previously that atypical MBCs, as a percentage of
total B cells, are expanded in children and adults exposed to
intense seasonal Pf transmission in Mali [15]. The objectives of the
present study were to determine if atypical MBC expansion is a
finding that can be generalized to Pf-exposed individuals in Peru,
and if there is a correlation between the degree of atypical MBC
expansion and Pf transmission intensity. We observed that atypical
MBCs were expanded in Pf-infected individuals in Peru relative to
Pf-naive individuals, and that the degree of atypical MBC
expansion increased with increasing Pf transmission intensity,
consistent with the hypothesis that Pf infection drives the
expansion of atypical MBCs.
Although this study further strengthens the association between
Pf infection and atypical MBCs, a causal relationship remains to
be established. Many factors associated with Pf transmission could
Figure 2. Atypical MBCs in Peruvian adults by self-reported
history of prior malaria episodes. Atypical MBCs were detected by
flow cytometry and expressed as a percentage of total B cells in the
peripheral blood of Pf-infected Peruvian adults who did (n=12) or did
not (n=6) self-report a prior history of malaria. Box-and-whisker plots
represent the smallest and largest values (whiskers), the lower and
upper quartiles (top and bottom of box), and the median (horizontal
line across box). The Mann-Whitney test was used to compare
continuous variables between groups.
doi:10.1371/journal.pone.0015983.g002
Figure 3. Phenotypic analysis of B cell subsets in individuals
from the U.S., Peru and Mali. The following B cell subsets were
quantified by flow cytometry, as detailed in Materials and Methods:
plasma cells/blasts (CD19
+ CD21
2 CD20
2), activated MBCs (CD19
+
CD21
2 CD27
+CD20
+), classical MBCs (CD19
+ CD27
+ CD21
+), atypical
MBCs (CD19
+ CD20
+ CD21
2 CD27
2 CD10
2) naive B cells and immature
B cells (CD19
+ CD10
+). B cell subsets are expressed as a percentage of
total CD19
+ B cells in the peripheral blood of Pf-naive U.S. adults
(n=10), Pf-infected Peruvian adults (n=18) and Pf-infected Malian
adults (n=12). The relative proportions of B cell subsets are shown in
stacked plots.
doi:10.1371/journal.pone.0015983.g003
Figure 1. Atypical MBCs in individuals from the U.S., Peru and
Mali. Atypical MBCs were detected by flow cytometry and expressed as
a percentage of total B cells in the peripheral blood of Pf-naive U.S.
adults (n=10), Pf-infected Peruvian adults (n=18) and Pf-infected
Malian adults (n=12). Box-and-whisker plots represent the smallest and
largest values (whiskers), the lower and upper quartiles (top and
bottom of box), and the median (horizontal line across box). The Mann-
Whitney test was used to compare continuous variables between
groups.
doi:10.1371/journal.pone.0015983.g001
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Mali, including concurrent helminth infections, cumulative
exposure to other pathogenic and non-pathogenic microbes, and
malnutrition. It will be important to examine the role of these and
other factors in the expansion of atypical MBCs in future studies.
Although we previously reported a lack of association between
concurrent intestinal helminth infection and the degree of atypical
MBC expansion [15], this observation needs to be confirmed in
other studies. It is unlikely that HIV drives the atypical MBC
response observed in the present study since the prevalence of HIV
is ,1.5% in the areas of Mali [21] and Peru (O. Branch,
unpublished data) where this study was conducted. It also seems
less likely that host genetic factors play a role in atypical MBC
expansion since this study suggests that atypical MBCs appear to
be a generalizable finding in Pf-exposed individuals of different
ethnic backgrounds on separate continents.
From an epidemiological standpoint, additional studies are
needed to further test the hypothesis that Pf infection drives the
atypical MBC response. For example, comparing B cell subsets of
genetically related individuals living under similar conditions with
the exception of Pf exposure would help isolate the effect of Pf
infection on atypical MBC expansion. Tracking B cell profiles
longitudinally in individuals residing in areas where Pf transmis-
sion is rapidly decreasing [22], or in individuals emigrating from Pf
endemic areas could also provide insights into the temporal
relationship between Pf exposure and the longevity of atypical
MBCs. Additionally, B cell profiles of children in the treatment
and control arms of trials of intermittent preventive treatment
(IPTc) of malaria [23] could be compared to determine if and how
decreased Pf exposure influences the atypical MBC response.
The specificity and function of atypical MBCs in the context of
Pf infection remains to be determined. In the case of HIV, Moir
et al found that HIV-specific MBCs were enriched in ‘exhausted’
MBCs whereas the total immunoglobulin and influenza-specific
responses were enriched in classical MBCs [17]. Further studies
are needed to determine the degree to which atypical MBCs are
Pf-specific. Obstacles in this regard are the relatively low frequency
of MBCs of any given antigen specificity in the peripheral
circulation and the small volumes of blood typically collected in
field studies. The latter could be overcome by establishing safe and
reliable leukopheresis facilities where such studies are done.
Regarding the function of atypical MBCs, Ehrhardt et al, who
first described FCRL4
+ ‘tissue-like’ MBCs in the lymphoid tissue
of healthy individuals [16], suggested that these cells may protect
against invasive pathogens possibly through their influence on
other cells, either directly or indirectly through the secretion of
cytokines [24,25]. In contrast, Moir et al. suggested that this subset
of hyporesponsive, or ‘exhausted’ FCRL4
+ MBCs contribute to
the B cell deficiencies observed in HIV-infected individuals [17].
By analogy, it is possible that atypical MBCs confer protection
against malaria by contributing to the regulation of the host
immune response; on the other hand, it is also conceivable that
exhaustion of Pf-specific MBCs through repeated infections
contributes to the inefficient acquisition and relatively rapid loss
of Pf-specific MBCs and long-lived antibodies that we have
observed in the same study population in Mali [12,13].
Immunoglobulin class switching and somatic hypermutation occur
simultaneously in germinal center reactions during the differen-
tiation of naı ¨ve B cells into MBCs. More than half of the atypical
MBCs detected in individuals in Peru and Mali expressed surface
IgG, indicating that at least a portion of these cells have passed
through a germinal center reaction. This is consistent with models
in which atypical MBCs are either the product of a dysfunctional/
aborted germinal center reaction, or arise from pre-existing
classical MBCs; either scenario could lead to a diminished classical
MBC response.
In summary, this study provides evidence that atypical MBC
expansion is a generalizable finding in Pf-exposed populations, and
that the magnitude of the atypical MBC response increases with
increasing Pf transmission intensity. Further studies are needed to
define the origin, function and antigen specificity of atypical MBCs
in the context of malaria.
Materials and Methods
Peru study site and participants
The Malaria Immunology and Genetics in the Amazon
(MIGIA) study began in 2003 and is ongoing in an area just
south of Iquitos, Peru, as detailed elsewhere [26]. Pf and
Plasmodium vivax (Pv) transmission at this site occurs during the
rainy season from January through July. Although entomological
inoculation rate (EIR) data is not available at this site, the
incidence of symptomatic Pf and Pv infection was low in 2003—
approximately 0.03 and 0.22 infections/person/malaria season,
respectively [26]. The period prevalence of asymptomatic Pf and
Pv infection by blood smear during one month at the beginning of
the malaria season in 2003 was approximately 12.5% and 37.8%,
respectively [26]. The present cross-sectional study includes 18
adults who presented to the study clinic with symptomatic Pf
infection during the 2009 malaria season. At enrolment a
physician examined the study participants and solicited a medical
history which included the self-reported number of prior malaria
episodes. A finger-prick blood sample was obtained for a blood
smear and 8ml of venous blood were drawn for analysis by flow
cytometry. After the blood draw, malaria treatment was provided
following international standards. The Ethical Review Board of
the Peruvian National Institute of Health and Ministry of Health,
Figure 4. Atypical MBCs and immunoglobulin class switching.
Class-switching of atypical MBCs was assessed by measuring cell surface
expression of IgG by flow cytometry in the peripheral blood of Pf-naive
U.S. adults (n=10), Pf-infected Peruvian adults (n=18) and Pf-infected
Malian adults (n=12). Box-and-whisker plots represent the smallest and
largest values (whiskers), the lower and upper quartiles (top and
bottom of box), and the median (horizontal line across box). The Mann-
Whitney test was used to compare continuous variables between
groups.
doi:10.1371/journal.pone.0015983.g004
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and the University of Alabama approved this study. Written,
informed consent was obtained from all study participants.
Mali study site and participants
In May 2006 an observational cohort study of naturally-
acquired malaria immunity was initiated in Kambila, Mali, a rural
village with a population of 1500 located 20 km north of the
capital of Bamako. A detailed description of the study site and
cohort design are reported elsewhere [27]. Pf transmission is
seasonal and intense at this site from July through December. The
entomological inoculation rate measured in a nearby village was
approximately 50–60 infective bites/person/month in October
2000 and fell to near zero during the dry season [28]. The present
cross-sectional study includes 12 adults enrolled in the cohort study
who had a blood smear positive for Pf at a scheduled follow-up
visit during the 2006 malaria season, and who had an available
sample of frozen peripheral blood mononuclear cells (PBMCs) that
had been drawn during the same visit. As is typical in Mali, these
Pf-infected adults had no signs or symptoms of malaria when the
blood smear was prepared and they were not treated with anti-
malarial drugs (the blood smear was not read immediately). The
Ethics Committee of the Faculty of Medicine, Pharmacy, and
Odonto-Stomatology, and the IRB at the National Institute of
Allergy and Infectious Diseases (NIAID), National Institutes of
Health (NIH) approved this study (protocol # 06-I-N147).
Written, informed consent was obtained from all study partici-
pants.
U.S. blood donors
PBMCs from ten healthy adult blood bank donors in the U.S.
were also analyzed. Demographic and travel history data were not
available from these anonymous donors but prior Pf exposure is
unlikely. Blood samples were obtained for research use after
written informed consent was obtained from all study participants
enrolled in a protocol approved by the IRB of NIAID, NIH
(protocol # 99-CC-0168).
PBMC collection
In Peru, Mali, and the U.S., blood samples were drawn by
venipuncture into sodium citrate-containing cell preparation tubes
(BD, Vacutainer CPT Tubes). PBMCs were isolated according to
the manufacturer’s instructions and frozen in fetal bovine serum
(FBS) (Gibco, Grand Island, NY) containing 7.5% dimethyl
sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO). PBMCs were
kept at 280uC for 24 hours and then transferred to 2196uC in the
U.S. and Mali, or 2135uC in Peru. We verified previously that the
expansion of atypical MBCs is not an artifact of freezing and
thawing PBMCs [15].
Phenotypic analysis of B cell subsets
All phenotypic analyses were performed using mouse monoclon-
al antibodies specific for human B cell markers conjugated to
fluorophores as previously reported [29]. Fluorophore-conjugated
monoclonal antibodies specific for the following markers were used:
PECy7-CD19, PE-CD20, APC-CD10, APC-CD27, PE-IgG (BD
Biosciences, San Jose, CA) and FITC-CD21 (Beckman Coulter,
Fullerton, CA). A four-color, two-stain strategy was used to identify
B cell subsets as follows: plasma cells/blasts (CD19
+ CD21
2
CD20
2),immatureBcells(CD19
+CD10
+),classicalMBCs(CD19
+
CD27
+ CD21
+), atypical MBCs (CD19
+ CD20
+ CD21
2 CD27
2
CD10
2andactivatedMBCs (CD19
+CD21
2CD27
+CD20
+).Aswe
and Moir et al previously reported, FCRL4 is primarily expressed
on the CD19
+ CD20
+ CD21
2 CD27
2 CD10
2 B cell subset;
however, levels of FCRL4 expression are variable whereas CD20
clearly and consistently delineates the atypical memory B cells
[15,17]. FACS analyses were performed on a FACSCalibur flow
cytometer (BD Biosciences) using FlowJo software (Tree Star,
Ashland, OR).
Measurement of peripheral blood Pf parasitemia
In Mali and Peru, thick blood smears were stained with Giemsa
and counted against 300 leukocytes. Pf densities were recorded as
the number of asexual parasites/ml of whole blood, based on an
average leukocyte count of 7500/ml in Mali and 6000/ml in Peru.
Each smear was evaluated separately by two expert microscopists
blinded to the clinical status of study participants. Any
discrepancies were resolved by a third expert microscopist.
Statistical analysis
Data were analyzed using GraphPad Prism for Windows
(GraphPad Software, version 5.02).The non-parametric Mann-
Whitney test was used to compare continuous variables between
groups, and the Fisher’s exact test was used to compare categorical
variables. For all tests, two-tailed p values were considered
significant if #0.05.
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